Image: Indi Deol, Managing Director of Innovation Birmingham-based DESIblitz
The Scotland team of coaches and consultants with BioCity’s Toby Reid (Managing Director) and Colin Roberts (Director of Venture Development).
Four colleagues, who previously worked together in the Innovative Medicines Unit (IMU) at Grünenthal, have combined their strategic and operational R&D expertise to launch a new life sciences consultancy, TherapeutAix, based in Aachen, Germany.
Specialising in fibrotic disease, inflammation and orphan indications, but with a track record across multiple therapeutic areas, TherapeutAix combines hands-on experience with an integrated R&D network to help medicines reach patients.
A special team of industry experts have been appointed to provide business and technical support to the growing number of SMEs based at leading science campus Sci-Tech Daresbury.
Grant Thornton, IBM, Marks & Clerk, Michael Page, RTC North, Slater Heelis and the University of Liverpool have been announced as Sci-Tech Daresbury’s seven Gold Partners for 2018/19.
Venturefest West Midlands set to boost growth for the region's brightest science and tech innovators
For the fourth year, Venturefest West Midlands will be providing an arena for the region’s brightest entrepreneurs, innovators and investors to grow and collaborate whilst exploring new products and services.
Tailored for growth-focused businesses in the science and technology sector, the single-day event will be taking place on Thursday 27th September at Innovation Birmingham’s iCentrum facility.
Image: Janet Todd (left) Manager of NETPark with Dr Stuart Cockerill, ReViral
A PIONEERING biotechnology firm will start the next phase of clinical trials of its antiviral drug early next year after winning US$55 million from US and European investors.
Image: (left) Dr John Brown, Chair of BioCity group and Stuart Henderson
BioCity, the Nottingham-headquartered life sciences incubation business, has appointed Stuart Henderson to the Board to help drive its growth and further strengthen its connections within the life sciences sector.
Aerodynamics specialist TotalSim has chosen Silverstone Park to develop a new 26,000 sq ft state-of-the-art sports engineering facility which it believes will have “global appeal”.
The exciting project – named the Silverstone Sports Engineering Hub – benefits from a £2m BTVLEP grant and will comprise two wind tunnels: one for cycling and other sports such as wheelchair athletics, speed-skating, skeleton and running; the other for testing fabrics.
Offices, design studios and workshops for production, prototyping and testing will also be included.
PHILADELPHIA, PA, USA: Ossianix, Inc. today announced a research collaboration and option agreement with Novo Nordisk to deliver therapeutic molecules in diabetes and other metabolic diseases across the Blood Brain Barrier (BBB) to the brain.